|
|
|
|
|
by fozzieBoston
4424 days ago
|
|
Cipla was discussed as a Harvard Business School case in the Corporate Accountability class this year (I'm a student at the school). It is an interesting ethical debate - do you allow companies to take patented technologies, improve processes, and overpass patents? are patents granted in the US even valid in India? does Cipla hurt or help the drug industry? It is a long and tough debate, and there is no right answer. However, for those that think Cipla is all about saving the world, remember that it is a for-profit company. Furthermore, keep in mind that drug companies use profits from current drugs to develop future drugs. By reducing their profits now you reduce their ability to develop life saving drugs in the future. The pharma model relies on blockbuster drugs, and ~5000 drug developments start for every blockbuster drug that ends. With those odds, damaging their margins does have a massive effect on their long term ability. No right answers here... but it is definitely not as simple as Cipla makes it to be. |
|
Now, don't get me wrong. Some of these organizations do a whole world of good, have very passionate and dedicated individuals that are probably working for free, and there are a lot of causes that benefit greatly from their presence. But let's not fool ourselves into putting non-profit organizations on an almighty moral pedestal where we claim they can do no wrong. While simultaneously demonizing organizations that try to make a profit out of giving people what they want/need.